Dr. Barry W. Goy explains how to interpret PSA levels after prostate cancer treatment and how to manage recurrence based on ...
Pfizer’s Talzenna in combi with Xtandi improves survival outcomes in metastatic castration resistant prostate cancer: New York Saturday, February 15, 2025, 11:00 Hrs [IST] Pfize ...
The Healthy @Reader's Digest on MSN13h
OTC Medication Mistakes: Doctors Advise You To Avoid Doing TheseJust because you can buy a medication over the counter doesn’t mean it’s always safe. Here’s how you should really be using ...
PM NEWS Nigeria on MSN7h
Rising cases of childhood cancer in Nigeria: Hope on the horizon?In Nigeria, survivors recall nauseating experiences, while relevant authorities, stakeholders and health experts are stepping ...
Hair loss can be traumatic and, unfortunately, extremely common. But a New Jersey doctor says he has a new treatment.
Enfortumab vedotin with or without pembrolizumab offers disease control benefits for patients with upper tract urothelial cancer, said Evangelia Vlachou, MD, of Johns Hopkins Medicine.
The Faculty of Medicine at Imperial is a world-class teaching, learning and research environment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback